Walleye Capital LLC Veru Inc. Transaction History

Walleye Capital LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$10.22 - $23.7 $980,210 - $2.27 Million	95,911 New	95,911 $1.11 Million
Q2 2022 Aug 08, 2022	SELL	$4.35 - $15.85 $148,335 - $540,485	-34,100 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.55 - $6.41 $155,155 - $218,581	34,100 New	34,100 $165,000
Q2 2021 Aug 16, 2021	SELL	$7.24 - $11.2 $649,898 - $1.01 Million	-89,765 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$8.05 - $20.78 $722,608 - $1.87 Million	89,765 New	89,765 $967,000
Q1 2020 May 15, 2020	SELL	$2.58 - $4.58 $181,392 - $322,006	-70,307 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.86 - $3.35 $130,771 - $235,528	70,307 New	70,307 $236,000

123

56.9M

668K

531K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $53.7M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.